Navigation Links
Pharmacists Report Patients do not Treat Cold and Flu Symptoms Early Enough, New Survey Shows
Date:11/10/2009

SCOTTSDALE, Ariz., Nov. 10 /PRNewswire/ -- A recent national survey of 505 pharmacists found that nine out of 10 pharmacists believe it is important for a patient to seek treatment early to help shorten the duration and severity of a cold. And 75 percent of pharmacists say most patients should purchase over-the-counter (OTC) cold and flu products at the first sign of symptoms, while only 26 percent of their patients take this proactive approach.

According to the survey, pharmacists are increasingly playing a more prominent role in patient care due to the anticipated severity of the upcoming cold and flu season and the current state of the economy. The survey also showed 87 percent of pharmacists anticipate an overall increase in the number of cold and flu patients seeking their counsel and 85 percent agree that the economic downturn will specifically lead more patients to first come to their pharmacist rather than a physician.

"Early preparedness is going to be more important this cold and flu season; however, even with the threat of stronger, more virulent infections, pharmacists note that patients oftentimes delay treatment allowing a virus to live longer," said Dr. Fred Eckel, Professor of Pharmacy Practice and Experiential Education at the University of North Carolina Chapel Hill Eshelman School of Pharmacy. "Pharmacists are the most accessible health care provider for patients with cold and flu symptoms and the survey findings emphasize the important role of the pharmacist in educating patients with information about early treatment to shorten the duration and severity of a cold."

The objectives of the survey were to understand the pharmacist's insight and role in providing recommendations for this upcoming cold and flu season. The survey, entitled "National Pharmacist O.T.C. (Observations on the Treatment of Colds)" was sponsored by Matrixx Initiatives, Inc. an OTC healthcare company, and makers of Zicam products.

Other key findings from the survey include:

  • Eighty-five percent of pharmacists agree the economy has increased the number of patient questions about OTC products.
  • Eighty-one percent of pharmacists agree that more patients are opting to purchase OTC medications versus filling prescriptions due to the economic downturn.
  • Eighty-one percent of pharmacists report making five or more recommendations per day for OTC cold and flu products.

"We know from the survey that pharmacists are making a fair amount of daily recommendations for OTC products," says Dr. Eckel. "Those who believe it's important for patients to seek treatment early, at the first sign of cold symptoms, are recommending oral zinc-based remedies, like Zicam, in order to shorten the duration and severity of a cold."

About the Survey

The survey, conducted in September 2009, was based on a nationally representative random sample of 505 pharmacists working in independent and chain pharmacies. The sample frame was developed using Medical Marketing Service, Inc.'s Pharmacies list, that includes more than 68,000 pharmacies and is updated monthly. Only one pharmacist was allowed to respond per pharmacy. Richard Day Research, Inc. was responsible for survey design, data analysis and reporting.

About Zicam Cold Remedy

Most cold medicines are designed to mask cold symptoms; however, Zicam Cold Remedy is different. When taken at the first sign of a cold (within the first 24-48 hours), Zicam Cold Remedy products, which use propriety formulations of zinc gluconate and zinc acetate as the active ingredients, reduce the duration and severity of the common cold when used as directed. Two new Cold Remedy items, Zicam Cold Remedy Zavors and Zicam Cold Remedy Plus Liqui-Loz, are also available on retailer shelves this cold season.

About Matrixx Initiatives, Inc.

Matrixx Initiatives, Inc. is engaged in the development and marketing of over-the-counter health care products that utilize innovative drug delivery systems. Zicam, LLC, its wholly-owned subsidiary, manufactures and markets a full line of Zicam brand pharmaceuticals, including Zicam Cold Remedy Chewables; Zicam Cold Remedy Oral MistTM; Zicam Cold Remedy RapidMelts®; Zicam Allergy ReliefTM; Zicam Extreme Congestion ReliefTM; Zicam Sinus ReliefTM; as well as Zicam Cough products and Zicam Multi-Symptom relief items. For more information regarding Matrixx products, please visit www.Zicam.com.

    Contact:
    Sarah Sanders
    GolinHarris
    312-729-4414
    ssanders@golinharris.com

SOURCE Matrixx Initiatives, Inc.


'/>"/>
SOURCE Matrixx Initiatives, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. CVS Caremark Celebrates Outstanding Pharmacy Care to Patients During American Pharmacists Month in October
2. National Pharmacy Technician Day: Pharmacy Technician Certification Board (PTCB) Recognizes Pharmacy Technicians During Octobers American Pharmacists Month
3. Confusion over Influenzinum Clarified by the American Association of Homeopathic Pharmacists (AAHP)
4. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
5. Spherix Reports Second Quarter Earnings
6. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
7. Tapestry Reports Second Quarter 2007 Results
8. Callisto Reports on Second-Quarter 2007 Milestones
9. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
10. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
11. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... SAN FRANCISCO , April 27, 2016 /PRNewswire/ ...  is expected to reach USD 2.06 billion by ... View Research, Inc. Increasing consumer awareness towards a ... over the next seven years.      ... Improper diet intake coupled with rising health treatment ...
(Date:4/26/2016)... Mich. , April 26, 2016 Diplomat ... promotion of Jennifer Hagerman , Pharm D., to ... her growing role at Diplomat, Hagerman will continue to ... the company that delivers custom education and training to ... the specialty pharmacy industry. Diplomat University also houses the ...
(Date:4/26/2016)... 2016 US demand for infection prevention ... percent annually to $27.6 billion in 2020.  Increasing ... decrease rates of healthcare-associated infections (HAIs) will boost ... services.  Although declining, the overall rate of certain ... set by the CDC.  Recent statistics indicate that ...
Breaking Medicine Technology:
(Date:4/29/2016)... ... 2016 , ... Mercy College is expanding its Graduate Business Programs to the ... due to high demand: Master of Business Administration (MBA), Master of Organizational Leadership (MSOL) ... , School of Business Graduate Program Chair Dr. Ray Manganelli said: “We believe that ...
(Date:4/29/2016)... ... April 29, 2016 , ... Our bodies are bombarded ... to confront and deal with these stressors is to adopt a more healthful diet, ... for you. Risa Groux, a certified Holistic Nutritionist and the creator of the Newport ...
(Date:4/29/2016)... ... 2016 , ... Conditions were ideal for Global Lyme Alliance’s (GLA) 2nd annual ... skies, a light breeze and temperatures in the 60s. Over 400 runners, walkers and ... Walk and 1-mile walk were held to increase awareness about Lyme disease and ...
(Date:4/29/2016)... ... 29, 2016 , ... Mobility Designed is redefining mobility with their patent ... M+D Crutch evenly distributes body weight from the elbow to the forearm. In ... crutches than with other crutches. , Co-founders Max and Liliana Younger were inspired to ...
(Date:4/29/2016)... York, NY (PRWEB) , ... April 29, 2016 , ... New York City based oral ... . This surgery is a very effective way to treat obstructive sleep apnea. Dr. Jamali ... , Orthognathic surgery is a procedure that involves one or both jaw bones. This surgery ...
Breaking Medicine News(10 mins):